224 related articles for article (PubMed ID: 37422330)
1. Development of new anticoagulant in 2023: Prime time for anti-factor XI and XIa inhibitors.
Bentounes NK; Melicine S; Martin AC; Smadja DM; Gendron N
J Med Vasc; 2023 Apr; 48(2):69-80. PubMed ID: 37422330
[TBL] [Abstract][Full Text] [Related]
2. [New anticoagulants in 2024: Development of factor XI and XIa inhibitors].
Bentounes NK; Melicine S; Martin AC; Smadja DM; Gendron N
Ann Biol Clin (Paris); 2024 Apr; 82(1):9-23. PubMed ID: 38638015
[TBL] [Abstract][Full Text] [Related]
3. Factor XI Inhibitors for Prevention and Treatment of Venous Thromboembolism: A Review on the Rationale and Update on Current Evidence.
Nopp S; Kraemmer D; Ay C
Front Cardiovasc Med; 2022; 9():903029. PubMed ID: 35647061
[TBL] [Abstract][Full Text] [Related]
4. News at XI: moving beyond factor Xa inhibitors.
Fredenburgh JC; Weitz JI
J Thromb Haemost; 2023 Jul; 21(7):1692-1702. PubMed ID: 37116752
[TBL] [Abstract][Full Text] [Related]
5. Pharmacotherapy for stroke prevention in nonvalvular atrial fibrillation: current strategies and future directions.
Gómez-Outes A; Suárez-Gea ML; Pérez-Cabeza AI; García-Pinilla JM
Expert Opin Pharmacother; 2022 Dec; 23(17):1941-1955. PubMed ID: 36398362
[TBL] [Abstract][Full Text] [Related]
6. Targeting factor XI and factor XIa to prevent thrombosis.
Gailani D; Gruber A
Blood; 2024 Apr; 143(15):1465-1475. PubMed ID: 38142404
[TBL] [Abstract][Full Text] [Related]
7. Drug-Drug Interactions of FXI Inhibitors: Clinical Relevance.
Ferri N; Colombo E; Corsini A
Hematol Rep; 2024 Mar; 16(1):151-163. PubMed ID: 38534886
[TBL] [Abstract][Full Text] [Related]
8. Pharmacology and Clinical Development of Factor XI Inhibitors.
Greco A; Laudani C; Spagnolo M; Agnello F; Faro DC; Finocchiaro S; Legnazzi M; Mauro MS; Mazzone PM; Occhipinti G; Rochira C; Scalia L; Capodanno D
Circulation; 2023 Mar; 147(11):897-913. PubMed ID: 36913497
[TBL] [Abstract][Full Text] [Related]
9. Clinical Evaluation of Factor XIa Inhibitor Drugs: JACC Review Topic of the Week.
Harrington J; Piccini JP; Alexander JH; Granger CB; Patel MR
J Am Coll Cardiol; 2023 Feb; 81(8):771-779. PubMed ID: 36813377
[TBL] [Abstract][Full Text] [Related]
10. Factor XI: structure, function and therapeutic inhibition.
Ali AE; Becker RC
J Thromb Thrombolysis; 2024 Apr; ():. PubMed ID: 38622277
[TBL] [Abstract][Full Text] [Related]
11. Abelacimab: A leap forward in anticoagulation with FXI and FXIa Inhibition.
Badreldin HA; Alsuhebany N; Alzahrani M; Alshehri AM; Aldoughaim M; Alqifari S; Yassin O; Alfehaid L; Alqahtani T
Curr Res Pharmacol Drug Discov; 2024; 6():100179. PubMed ID: 38545505
[TBL] [Abstract][Full Text] [Related]
12. Asundexian: an oral small molecule factor XIa inhibitor for the treatment of thrombotic disorders.
D'Allesandro N; Cave B; Hough A
Future Cardiol; 2023 Aug; 19(10):477-486. PubMed ID: 37830334
[TBL] [Abstract][Full Text] [Related]
13. Recent advances in the discovery and development of factor XI/XIa inhibitors.
Al-Horani RA; Afosah DK
Med Res Rev; 2018 Sep; 38(6):1974-2023. PubMed ID: 29727017
[TBL] [Abstract][Full Text] [Related]
14. Factor XI inhibitors for the prevention of cardiovascular disease: A new therapeutic approach on the horizon?
Santagata D; Donadini MP; Ageno W
Blood Rev; 2023 Nov; 62():101119. PubMed ID: 37580207
[TBL] [Abstract][Full Text] [Related]
15. The hemostatic role of factor XI.
Puy C; Rigg RA; McCarty OJ
Thromb Res; 2016 May; 141 Suppl 2(Suppl 2):S8-S11. PubMed ID: 27207433
[TBL] [Abstract][Full Text] [Related]
16. Factor XI and coagulation. Factor XI inhibitors - antithrombotic perspectives.
Vlădăreanu AM; Roşca A
Rom J Intern Med; 2024 Jun; 62(2):91-100. PubMed ID: 38153875
[TBL] [Abstract][Full Text] [Related]
17. Factor XI, a potential target for anticoagulation therapy for venous thromboembolism.
Li T; Liu J; Wu W
Front Cardiovasc Med; 2022; 9():975767. PubMed ID: 36386334
[TBL] [Abstract][Full Text] [Related]
18. A Review of FXIa Inhibition as a Novel Target for Anticoagulation.
Koulas I; Spyropoulos AC
Hamostaseologie; 2023 Feb; 43(1):28-36. PubMed ID: 36807817
[TBL] [Abstract][Full Text] [Related]
19. A review of emerging factor XI inhibitors.
Elsheikh S; Tidbury N; Lip GYH
Expert Opin Emerg Drugs; 2023 Mar; 28(1):43-53. PubMed ID: 36927160
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of factor XIa as a new approach to anticoagulation.
Schumacher WA; Luettgen JM; Quan ML; Seiffert DA
Arterioscler Thromb Vasc Biol; 2010 Mar; 30(3):388-92. PubMed ID: 20139363
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
